Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
about
MicroRNAS in endometrial cancer: recent advances and potential clinical applicationsImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerMicroRNA-199b Modulates Vascular Cell Fate During iPS Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing VEGF SignalingMiR-199b-5p inhibits osteogenic differentiation in ligamentum flavum cells by targeting JAG1 and modulating the Notch signalling pathway.Circulating MicroRNAs in gynecological malignancies: from detection to predictionMiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinomaPathway analysis of microRNA expression profile during murine osteoclastogenesisA microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma.Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer.Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer.MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathwaysDownregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.MicroRNAs in normal and psoriatic skinPrognostic significance of microRNA-100 in solid tumors: an updated meta-analysis.Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.Clinic significance of microRNA-99a expression in human lung adenocarcinoma.MiR199b suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in prostate cancer cells.Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation.Quaking Is a Key Regulator of Endothelial Cell Differentiation, Neovascularization, and Angiogenesis.Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.Refute the conclusion made by Jie et al. in "prognostic role of microRNA-100 in various carcinomas: evidence from six studies".MicroRNA-99a is a novel regulator of KDM6B-mediated osteogenic differentiation of BMSCs.Discovery of biomarkers for endometrial cancer: current status and prospects.miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.Circulating serum miRNAs as potential biomarkers for nephroblastoma.miR-100 inhibits the migration and invasion of nasopharyngeal carcinoma by targeting IGF1R.MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cellsLiquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
P2860
Q26780358-40C49C0C-927A-4217-83D5-2555B2E624B7Q27016123-DC6557C7-07A2-4BC8-9D92-6090E3DA87E2Q28509253-7AC8A4F9-465B-4D02-A2EA-79F37BB5743CQ33684228-E12FD7AC-BFAE-44A0-91B2-A01782F27049Q33718986-9D1E5E69-6DDA-4809-A6D0-0D6D431F2261Q33815178-6100E7FF-DEA8-4BE7-B92D-994E433443C9Q34036145-D95D119C-D9B1-4034-BD2E-93AD33EE81D8Q34362064-2F4C27BC-1F05-4E45-BA95-771B7AFB3361Q35252690-506D91A6-37FE-48A0-BB1D-072EDE7E9623Q35562369-1030806B-7C7A-4B03-89F4-95D6248FB764Q36162978-D68CD371-7AA3-45B3-B7F5-70501C983AE6Q36418630-654E4E37-2224-448C-A3E4-E09B4ABD0B8DQ36517445-08011E39-105A-4162-969B-37CC94848F3BQ36841237-265819E6-72F7-48C9-998F-392A04B8A766Q36905747-EDF37AD0-70A4-4776-A438-CD632DD0E02CQ37053529-97F44025-DA68-45AB-B48A-2B833CD30D66Q37235553-75C1E1A7-AEC1-4E60-8797-2644F77C1AB0Q37376470-BD67A6DF-1734-4460-B8B3-527AD2B4A797Q37578229-A33780FB-5F72-4D8E-BA46-F00A7A207966Q37610478-CD9BF302-722C-4BE3-8470-053C7363DE4DQ37687451-F629D013-D585-43A3-99D1-685DB696358DQ38248819-62391FEE-E77D-46EA-9B79-68E5362E0F89Q38258014-48FAF407-2D60-49ED-9B2B-29231515FA58Q38362213-B9AB2931-B46C-4F1A-A97A-620A2E0E9543Q38367693-61779F3B-03B5-4F56-AE20-56F76A23D510Q39001625-05D0B5F7-71C7-42B6-B440-95D3574C83A8Q39119180-AFD9E2DE-ABB1-411D-9C0B-6F3F9561FC3DQ39164512-B2020AA6-DEC8-448A-A5CD-F050B188A494Q39317584-C34C3FE5-9753-4D87-9D1A-2B80E4296981Q40506554-8D3B8CB8-F2C6-48E9-9F83-AE0F4CFE8EB6Q42091587-3F3D3BDA-3359-47CC-BCB0-1B6F275E2853Q42365364-71FF6532-ED14-4F5B-BE93-60902DEAC526Q43579814-7AEC9AA6-8B1A-45F8-8241-6C5B8B810EBFQ48150873-016A679A-0049-44D6-B44A-8F0CB08999D1Q51341963-F7E487B4-0DEE-4087-ACE3-894072D06531Q53240276-944642A5-21AB-432C-A269-416D5A8BF153Q53573234-DC6C5CEA-1D8F-43FD-9E27-7CC22B125832Q55113280-368DBDD6-DA51-4052-8082-D1C5F07E5ECAQ57786973-E24819FA-C874-4CB4-892C-8BFFC756605BQ58796795-9522A302-8416-4E45-B6B7-E1DE476DAA37
P2860
Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@ast
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@en
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@nl
type
label
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@ast
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@en
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@nl
prefLabel
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@ast
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@en
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@nl
P2093
P2860
P356
P1433
P1476
Deregulation of miR-100, miR-9 ...... metrioid endometrial carcinoma
@en
P2093
Anna Pesci
Anna Torres
Marcello Ceccaroni
Paola Cassandrini
Ryszard Maciejewski
Tomasz Paszkowski
P2860
P2888
P356
10.1186/1471-2407-12-369
P407
P577
2012-08-24T00:00:00Z
P5875
P6179
1016244639